Back to Nuveen Asset Management, LLC Nuveen Asset Management, LLC

NVCR

Showing 2 of 28 quarters

Position history for Nuveen Asset Management, LLCNuveen Asset Management, LLC's holdings in NovoCure Limited

As of its last 13F, for Q4 2024, Nuveen Asset Management held 358,952 shares of NVCR (NovoCure), worth $10.7M. It reduced the position by 5,601 shares (-1.5%) from Q3 2024. Nuveen Asset Management held NVCR from Q1 2018 to Q4 2024, across 28 quarterly 13F filings.

Current Value

$10.7M

Current Shares

358,952

Total Value Change

+$5M

Total Shares Change

-5,601

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Decreased
358,952
-1.5%
$10.7M0.0%$29.80
0
2024-Q3
Decreased
364,553
-17.8%
$5.7M0.0%$15.63
0

Other major holders of NVCR: Capital World Investors, FMR LLC, Baillie Gifford & Co., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used